User blogs

Molnupiravir is a product approved by the FDA for emergency use in the treatment of COVID-19. Molnupiravir 200 mg capsulesare prescribed to adults 18 and older who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days, and have not been hospitalized. You must also be at high risk for COVID-19 complications due to advanced age, obesity, or ongoing medical conditions in order to receive this product (such as lung or heart disease or diabetes, among others). Discuss the risks and benef... more